Latest Breaking News On - Phase 2 tatcist trial nct05219500 - Page 1 : comparemela.com

PSMA-Directed Targeted Alpha Therapy Shows Activity in Heavily Pretreated Metastatic CRPC

FPI-2265 showed promising activity in patients with metastatic castration-resistant prostate cancer which was similar to prior safety and efficacy data reported.